{"Welcome.html": {"id": "Welcome.html", "text": "Welcome", "displayed_text": "Welcome"}, "Task.html": {"id": "Task.html", "text": "Task", "displayed_text": "Task"}, "ChangeTypes.html": {"id": "ChangeTypes.html", "text": "ChangeTypes", "displayed_text": "ChangeTypes"}, "Consent.html": {"id": "Consent.html", "text": "Consent", "displayed_text": "Consent"}, "Navigation.html": {"id": "Navigation.html", "text": "Navigation", "displayed_text": "Navigation"}, "Medicine_tweet_20": {"DOI": "10.1007/s00127-012-0548-z", "id": "Medicine_tweet_20", "News Finding": "PMDD (s\u00edndrome pre-menstrual) was strongly and independently associated with non-fatal suicidal behaviors \n", "Paper Finding": "These findings suggest that clinicians treating women with PMDD should assess and be vigilant for signs of suicidal behavior, and that clinicians might evaluate and treat the premenstrual symptoms of women who express suicidal ideation, plans, or attempts.", "News Context": "PMDD (s\u00edndrome pre-menstrual) was strongly and independently associated with non-fatal suicidal behaviors \n", "Paper Context": "In conclusion, this study is the first to demonstrate a strong, independent association between PMDD and suicidal ideation, plans, and attempts among a nationally representative sample of women. These findings suggest that clinicians treating women with PMDD should assess and be vigilant for signs of suicidal behavior, and that clinicians might evaluate and treat the premenstrual symptoms of women who express suicidal ideation, plans, or attempts. By targeting a gender-specific risk factor for non-fatal suicidal behavior, clinicians may be able to address a substantial public health problem among reproductive-aged women.", "scores": "[4.0, 4.0, 4.0, 3.0]", "field": "Medicine", "split": "train", "final_score": 3.75, "source": "tweets", "News URL": "464347933207691264", "text": "<b>Reported finding:</b> PMDD (s\u00edndrome pre-menstrual) was strongly and independently associated with non-fatal suicidal behaviors \n<br><b>Paper finding:</b> These findings suggest that clinicians treating women with PMDD should assess and be vigilant for signs of suicidal behavior, and that clinicians might evaluate and treat the premenstrual symptoms of women who express suicidal ideation, plans, or attempts.", "displayed_text": "<b>Reported finding:</b> PMDD (s\u00edndrome pre-menstrual) was strongly and independently associated with non-fatal suicidal behaviors \n<br><b>Paper finding:</b> These findings suggest that clinicians treating women with PMDD should assess and be vigilant for signs of suicidal behavior, and that clinicians might evaluate and treat the premenstrual symptoms of women who express suicidal ideation, plans, or attempts."}, "Medicine_240": {"DOI": "10.1210/jc.2013-2350", "id": "Medicine_240", "News Finding": "Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.", "Paper Finding": "In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS .", "News Context": "\"The Society's recommendations allow physicians to make the diagnosis if clear symptoms are present without resorting to universal hormone tests or ultrasound screening.\" In the CPG, The Endocrine Society recommends that a diagnosis be made if adult women have two of the three cardinal features of PCOS (diagnostic criteria supported by the NIH panel): * Excess production of male hormones called androgens. Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.", "Paper Context": "Women with PCOS should have BMI and blood pressure measured at each clinic visit (and consider waist circumference if nonobese; \u0546 36 inches is abnormal), and upon diagnosis of PCOS, additional testing should include a complete fasting lipid profile (total cholesterol, LDL-cholesterol, non-HDL-cholesterol, HDL-cholesterol, and triglycerides). In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS . Another marker of atherosclerosis, coronary artery calcification, is more common in women with PCOS than in controls, even after adjusting for the effects of age and BMI .", "scores": "[4.0, 4.0, 2.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.75, "source": "news", "News URL": "http://www.sciencedaily.com/releases/2013/10/131024121206.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29", "text": "<b>Reported finding:</b> Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.<br><b>Paper finding:</b> In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS .", "displayed_text": "<b>Reported finding:</b> Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.<br><b>Paper finding:</b> In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS ."}, "Medicine_tweet_19": {"DOI": "10.1001/jamapediatrics.2018.0302", "id": "Medicine_tweet_19", "News Finding": "Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" ", "Paper Finding": "Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality.", "News Context": "Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" ", "Paper Context": "CONCLUSIONS AND RELEVANCE Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality. Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality. Low vitamin D level status during pregnancy may expose the offspring to a suboptimal nutritional environment during critical phases of fetal development and may have long-term effects on offspring health outcomes.", "scores": "[5.0, 5.0, 4.0, 4.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.4, "source": "tweets", "News URL": "1001608339808108544", "text": "<b>Reported finding:</b> Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" <br><b>Paper finding:</b> Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality.", "displayed_text": "<b>Reported finding:</b> Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" <br><b>Paper finding:</b> Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality."}, "Medicine_80": {"DOI": "10.1002/emmm.201302567", "id": "Medicine_80", "News Finding": "\"We observed delayed onset of motor neuron dysfunction; we noted also that SMN2 mis-splicing increases during the late stages of SMA, likely accelerating its progression in the body.", "Paper Finding": "SMN2 mis-splicing increased during late-stage disease.", "News Context": "\"Our efforts to model the adult form of SMA were successful,\" says Kentaro Sahashi, M.D., Ph.D., a postdoctoral researcher and neurologist who is first author of the team's new paper. \"We observed delayed onset of motor neuron dysfunction; we noted also that SMN2 mis-splicing increases during the late stages of SMA, likely accelerating its progression in the body. We noted, importantly, marked liver and heart pathologies that were related to SMA's progression in adults.\"", "Paper Context": "Systemic ASO injection elicited marked liver and heart pathologies, and resulted in decreased levels of circulating IGF1. SMN2 mis-splicing increased during late-stage disease. Our study also suggests that high SMN levels are not as critical in adults, and there is a broad therapeutic time window for treatment of adult-onset SMA.", "scores": "[5.0, 5.0, 2.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.0, "source": "news", "News URL": "http://www.sciencedaily.com/releases/2013/09/130909093116.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29", "text": "<b>Reported finding:</b> \"We observed delayed onset of motor neuron dysfunction; we noted also that SMN2 mis-splicing increases during the late stages of SMA, likely accelerating its progression in the body.<br><b>Paper finding:</b> SMN2 mis-splicing increased during late-stage disease.", "displayed_text": "<b>Reported finding:</b> \"We observed delayed onset of motor neuron dysfunction; we noted also that SMN2 mis-splicing increases during the late stages of SMA, likely accelerating its progression in the body.<br><b>Paper finding:</b> SMN2 mis-splicing increased during late-stage disease."}, "Experience.html": {"id": "Experience.html", "text": "Experience", "displayed_text": "Experience"}, "End.html": {"id": "End.html", "text": "End", "displayed_text": "End"}}